Baiyunshan H1 Revenue Up 0.61%, Net Profit Down 16.7%, Sets Dividend
Baiyunshan reported first-half 2026 operating revenue of RMB 42.091 billion, up 0.61% year on year, while net profit attributable to shareholders fell 16.7% to RMB 2.096 billion. Basic earnings per share stood at RMB 1.289. The company also proposed a cash dividend of RMB 3 per 10 shares, including tax.
Baiyunshan disclosed its semi-annual report on August 21, 2026. In the first half of 2026, the company achieved operating revenue of RMB 42.091 billion, representing a year-on-year increase of 0.61%. Net profit attributable to shareholders of the listed company reached RMB 2.096 billion, down 16.7% compared with the same period last year. Basic earnings per share amounted to RMB 1.289.
The company simultaneously announced a proposed cash dividend of RMB 3 (including tax) for every 10 shares held.
Why this event matters
The event has a measured impact on 2 industrys. The strongest current signal is negative for Traditional Chinese Medicine, with intensity 30/100 and 60% confidence over a short term horizon.
Traditional Chinese Medicine
- Direction
- negative
- Intensity
- 30
- Confidence
- 60%
- Horizon
- Short term
Pharmaceuticals
- Direction
- negative
- Intensity
- 20
- Confidence
- 50%
- Horizon
- Short term
Impact figures are analytical estimates that combine direction, intensity, confidence and event importance. They are not investment advice.